These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2686815)

  • 1. Osteosarcoma--is there a role for oral low-dose methotrexate.
    Harris MB
    Cancer Invest; 1989; 7(4):357-60. PubMed ID: 2686815
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of methotrexate in osteosarcoma.
    Grem JL; King SA; Wittes RE; Leyland-Jones B
    J Natl Cancer Inst; 1988 Jul; 80(9):626-55. PubMed ID: 3286880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for osteosarcoma without high-dose methotrexate: another piece in the puzzle.
    Blay JY
    Onkologie; 2007 May; 30(5):226-7. PubMed ID: 17460415
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose methotrexate in osteosarcoma--Mayo Clinic studies.
    Edmonson JH
    NCI Monogr; 1987; (5):67-9. PubMed ID: 3481039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
    Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
    Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma.
    Delepine N; Delepine G; Cornille H; Brion F; Arnaud P; Desbois JC
    Anticancer Res; 1995; 15(2):489-94. PubMed ID: 7763028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative administration of high-dose methotrexate for osteosarcoma.
    Chan KW; Knowling MA; Duncan CP; Morton KS
    Can J Surg; 1984 May; 27(3):305-7, 309. PubMed ID: 6586272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
    Tunn PU; Reichardt P
    Onkologie; 2007 May; 30(5):228-32. PubMed ID: 17460416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate for the patient with osteogenic sarcoma.
    Nirenberg A
    Am J Nurs; 1976 Nov; 76(11):1776-80. PubMed ID: 136192
    [No Abstract]   [Full Text] [Related]  

  • 11. [Successful treatment with administration of systemic high dose methotrexate and intraarterial carboplatin for osteosarcoma of the skull: a case report].
    Kitai R; Sato K; Kodera T; Nakagawa T; Kabuto M; Kobayashi H; Kubota T; Nozaki J
    No Shinkei Geka; 1995 Feb; 23(2):157-61. PubMed ID: 7877737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma--experience in Korea cancer hospital.
    Lee SY; Jeon DG; Kim SS; Jang JJ; Cho KJ
    J Korean Med Sci; 1993 Apr; 8(2):121-6. PubMed ID: 8397928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mega doses of methotrexate in the treatment of osteosarcoma.
    Iqbal MP; Malik IA
    J Pak Med Assoc; 1990 Oct; 40(10):248-51. PubMed ID: 2123265
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adjuvant chemotherapy of osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
    Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
    Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
    Chuman H; Fukuma H; Beppu Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1736-43. PubMed ID: 2471460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study.
    Bacci G; Gherlinzoni F; Picci P; Van Horn JR; Jaffe N; Guerra A; Ruggieri P; Biagini R; Capanna R; Toni A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1337-45. PubMed ID: 3493903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comprehensive therapy of osteosarcoma using high doses of methotrexate--experience 1980-1983].
    Kofránek I; Matĕjovský Z; Kraus P; Trnka V
    Acta Chir Orthop Traumatol Cech; 1983 Oct; 50(5):462-8. PubMed ID: 6581662
    [No Abstract]   [Full Text] [Related]  

  • 20. A preliminary report of neoadjuvant chemotherapy NSH-7 study in osteosarcoma: preoperative salvage chemotherapy based on clinical tumor response and the use of granulocyte colony-stimulating factor.
    Wada T; Isu K; Takeda N; Usui M; Ishii S; Yamawaki S
    Oncology; 1996; 53(3):221-7. PubMed ID: 8643225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.